29th June 2017
- 0 comments
MIP Diagnostics Ltd, a Midlands-based life sciences start-up that develops “plastic antibodies” for a variety of applications has received £300,000 of follow-on funding from Mercia Fund Management for working capital growth.
...Register / Login now to read full story
In order to read the full story we need you to be registered with us, please click the links below to login or register.
Back to Homepage